MedicationCoupons.org: FDA approves new Tachycardia & Fibrillation generic Cordarone / Amiodarone

MIAMI - Aug. 24, 2016 - PRLog -- Last Thursday, the FDA approved Aurobindo's Cordarone generic (amiodarone hydrochloride) capsules. Cordarone is indicated to deal with recurrent heart rhythm issues. Its active component, Amiodarone, was first manufactured back in 1961, and it's use in the medical field for heart-related chest pain symptoms commenced in 1962.

Specifically, Amiodarone, is an antiarrhythmic medicine used to deal with and alleviate a number of forms of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, in addition to atrial fibrillation and paroxysmal supraventricular tachycardia.

It is usually administered by  mouth, intravenously, or intraosseously. For its oral administration to take effect, it may take a few weeks.

Aurobindo's generic Cordarone will become available in 200-mg dosage strength. The generic Cordarone's manufacturer, which is one of the largest pharmaceutical companies of  a 'Vertical Integration' business model in India, had 2016 revenues in the US of about $24.1 million.

*Get CORDARONE / AMIODARONE COUPONS at: http://MedicationCoupons.org